@article {19, editor = {,}, title = {Difflam - a topical NSAID}, volume = {24}, number = {5}, pages = {19--20}, year = {1986}, doi = {10.1136/dtb.24.5.19}, publisher = {British Medical Journal Publishing Group}, abstract = {Difflam (Riker), a topical anti-inflammatory drug, is marketed for the relief of symptoms of painful inflammatory conditions: the cream (benzydamine 3\%) for musculoskeletal conditions such as sprains, and the oral rinse (benzydamine 0.15\% in a green liquid*) for pharyngitis and stomatitis. Benzydamine seems to be the only non-salicylate NSAID marketed for topical use, apart from oxyphenbutazone (in Tanderil eye ointment).}, issn = {0012-6543}, URL = {https://dtb.bmj.com/content/24/5/19}, eprint = {https://dtb.bmj.com/content/24/5/19.full.pdf}, journal = {Drug and Therapeutics Bulletin} }